# Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ganglioside-gd2-as-a-therapeutic-target-for-antibody-mediated-therapy-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael Roth,Marissa Linkowski,John Tarim,Sajida Piperdi,Rebecca Sowers,David S. Geller,Jonathan Gill,Richard Görlick |
| Citations | 160 |
| DOI | 10.1002/cncr.28461 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.28461 |
| OpenAlex ID | https://openalex.org/W1513821330 |
| PMID | 24166473 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Jonathan Gill](https://scholariq.org/researchers/jonathan-gill/)

## Paper journal

- [Cancer](https://scholariq.org/journals/cancer/)

## Paper primary topic

- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)

## Paper topics

- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Glycosylation and Glycoproteins Research](https://scholariq.org/topics/glycosylation-and-glycoproteins-research/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.